CIK 0001426800 · Non-accelerated filer<br>Smaller reporting company
ASSEMBLY BIOSCIENCES, INC.
Sign in to watch- Ticker
- ASMB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (833) 409-4583
- Business address
- TWO TOWER PLACE, 7TH FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- VENTRUS BIOSCIENCES INC
- 4 Open-market sale Chief Financial Officer sold 2,020 shares at $2.22 ($4,479)
- 8-K Event Exit or restructuring costs · Executive or director change · Regulation FD disclosure
- 4 Open-market sale Chief Scientific Officer sold 4,164 shares at $1.92 ($8,005)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change · Bylaws or fiscal year change · Shareholder vote results
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Open-market sale Chief Financial Officer sold 2,285 shares at $2.17 ($4,953)
- 4 Open-market sale Chief Medical Officer sold 1,038 shares at $2.17 ($2,250)
- 4 Open-market sale Chief Scientific Officer sold 1,038 shares at $2.17 ($2,250)
Page 14 of 46 · 903 filings